tiprankstipranks
Regencell Bioscience Holdings Ltd. (RGC)
NASDAQ:RGC
US Market
RGC
Regencell Bioscience
RESEARCH TOOLSreports
Want to see RGC full AI Analyst Report?

Regencell Bioscience (RGC) Income Statement

620 Followers

Regencell Bioscience Income Statement

Last quarter (Q4 2025), Regencell Bioscience's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Regencell Bioscience's net income was $-1.73M. See Regencell Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -392.74K$ -745.59K$ -769.69K$ -604.40K$ -26.46K
Operating Expenses
$ 3.38M$ 3.99M$ 6.27M$ 7.62M$ 1.38M
Depreciation and Amortization
$ 392.74K$ 745.59K$ 769.69K$ 604.40K$ 26.46K
EBITDA
$ -3.19M$ -3.62M$ -5.29M$ -6.99M$ -1.35M
Operating Income
$ -3.77M$ -4.74M$ -6.27M$ -7.62M$ -1.38M
Other Income/Expenses
$ 185.77K$ 373.50K$ 211.34K$ 23.21K$ 34.62K
Pretax Income
$ -3.58M$ -4.36M$ -6.06M$ -7.59M$ -1.35M
Net Income
$ -3.58M$ -4.30M$ -5.87M$ -7.42M$ -1.35M
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ -0.01$ -0.02$ 0.00
Diluted EPS
$ -0.01$ -0.01$ -0.01$ -0.02$ 0.00
Weighted Average Shares Outstanding
 494.49M 494.49M 494.49M 494.49M 480.40M
Weighted Average Shares Outstanding (Diluted)
 494.49M 494.49M 494.49M 494.49M 480.40M
Currency in USD

Regencell Bioscience Earnings and Revenue History